1.   Among Nasdaq stocks, the technology sector got hit hard and, within it, the biotechnology sector got clobbered.

2.   Analysts also said investors are taking another look at the U.K. biotechnology sector in light of positive news from two other companies.

3.   After a staggering cycle, the biotechnology sector is back to just about where it was at the beginning of the year.

4.   Early last summer, the managers became convinced that the biotechnology sector was starting a period of prolonged growth.

5.   Ian White, analyst at Robert Fleming Securities, said the rise in the U.K. biotechnology sector has more to do with individual stocks than broad-sector investing.

6.   Investors are regaining lost confidence in the battered biotechnology sector as major biotech companies report promising research breakthroughs, according to Biotechnology Investments Ltd.

7.   Positive results from at least some of these events are likely to push both the U.S. and U.K. biotechnology sectors higher, Werther predicted.

8.   Researchers will study most closely the technology, entertainment, banking and biotechnology sectors.

9.   Rigel Pharmaceuticals, a member of the fast-cooling biotechnology sector, reduced its rescheduled offering in size and price, then postponed it.

10.   The drop was not confined to the biotechnology sector.